SCHEMBL3783489

SCHEMBL3783489

CC(C)(C)OC(=O)N1CCC(O)(c2ccccc2OC(F)(F)F)CC1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.48
PKLR P30613 1/20 0.48
TACR1 P25103 1/20 0.44
GPR119 Q8TDV5 2/20 0.43
TSHR P16473 2/20 0.42
ALOX15 P16050 1/20 0.42
ATM Q13315 1/20 0.42
HDAC1 Q13547 2/20 0.41
HDAC8 Q9BY41 2/20 0.41
HDAC6 Q9UBN7 2/20 0.41
KDM1A O60341 2/20 0.41
RORC P51449 1/20 0.40
LIPE Q05469 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
OPRD1 P41143 2/20 0.39
OPRK1 P41145 2/20 0.39
OPRM1 P35372 1/20 0.39
OPRL1 P41146 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15595109 0.96 PKLR (0.45) PDK2PKLRTACR1GPR119TSHR
SCHEMBL2782630 0.90 PDK2 (0.44) PDK2PKLRTACR1GPR119TSHR
SCHEMBL6160222 0.86 OPRM1 (0.53) PDK2PKLRGPR119TSHRALOX15
SCHEMBL3326302 0.83 PDK2 (0.50) PDK2TACR1GPR119TSHRALOX15
SCHEMBL1513306 0.83 PDK2 (0.49) PDK2TACR1GPR119TSHRALOX15
SCHEMBL1106925 0.81 OPRD1 (0.42) PDK2TACR1GPR119TSHRALOX15
SCHEMBL3249913 0.81 OPRD1 (0.49) PDK2TACR1GPR119TSHRALOX15
SCHEMBL15807268 0.81 PDK2 (0.42) PDK2TACR1GPR119TSHRALOX15
SCHEMBL4699744 0.81 ALDH1A1 (0.47) PDK2GPR119TSHRALOX15ATM
SCHEMBL6918765 0.81 OPRM1 (0.47) PDK2PKLRGPR119TSHRALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010081904-A1 4 ( 1H) -PYRIDINONE DERIVATIVES AND THEIR USE AS ANTIMALARIA AGENTS GLAXO GROUP LIMITED (GB) 2010-07-22 WO disclosed